Aggregating human platelets stimulate the expression of thrombin receptors in cultured vascular smooth muscle cells via the release of transforming growth factor-β1 and platelet-derived growth factor(AB)

Circulation

Volumn 96, Issue 11, 1997, Pages 3888-3896

  Schini Kerth, Valérie B ^a   Bassus, Steffen ^b   Fisslthaler, Beate ^a   Kirchmaier, Carl M ^b   Busse, Rudi ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Blutspendedienst Hessen   (Germany)

Author keywords

Arteriosclerosis; Muscle,smooth; Platelet derived factors; Receptors; Thrombin

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; THROMBIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE;

EID: 0030657667     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.11.3888     Document Type: Article

References (61)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Ross R, Raines EW, Bowen-Pope DF. The biology of plateletderived growth factor. Cell. 1986;46:155-169.
3. Oka Y, Orth DN. Hainan plasma epidermal growth factor/βurogastrone is associated with blood platelets. J Clin Invest. 1983; 72:249-259.
4. α amino acid sequence analysis. Blood. 1989;74: 1084-1092.
5. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-β in human platelets: identification of a major storage site, purification, and characterization. J.Biol Chem. 1983;258:7155-7160.
6. Mannaras VJ, Mimikos N, Enzymic formation of serotonin in mammalian blood platelets and red cells. Experientia. 1971;27: 196-197.
7. Crowley ST, Dempsey EC, Horwitz KB, Horwitz LD. Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate. Circulation. 1994;90:1908-1918.
8. 2 Science. 1976;193:1135-1137.
9. Chen LB, Buchanan JM. Mitogenic activity of blood components, I: thrombin and prothrombin. Proc Natl Acad Sci U S A. 1975;72: 131-135.
10. Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci U S A. 1992;89:2317-2320.
11. Gordon EM, Venkatesan N, Salazar R, Tang H, Schmeidler-Sapiro K, Buckley S, Warburton D, Hall FL. Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase. Proc Natl Acad Sci U S A. 1996;93:2174-2179.
12. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 1990;111:2149-2158.
13. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of fibroblast growth factor in vascular lesion formation. Circ Res. 1991;68:106-113.
14. 1 during repair of arterial injury. J Clin Invest. 1991;88:904-910.
15. Cercek B, Fishbein MC, Forrester JS, Helfant RH, Fagin JA. Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res. 1990;66:1755-1760.
16. Wilentz JR, Sanborn TA, Haudenschild CC, Valeri CR, Ryan TJ, Faxon DP. Platelet, accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation. 1987;75: 636-642.
17. Hatton MWC, Moar SL, Richardson M, Deendothelialization in vivo initiates a thrombogenic reaction at the rabbit aorta surface: correlation of uptake of fibrinogen and antithrombin III with thrombin generation by the exposed subendothelium. Am J Pathol. 1989;135:499-508.
18. Herbert JM, Lamarche I, Dol F. Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor: effect of heparin. FEBS Lett. 1992;301:155-158.
19. McNamara CA, Sarembock IJ, Gimple LW, Fenton JW II, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest. 1993;91:94-98.
20. Vu T-KH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057-1068.
21. 2+ mobilization. FEBS Lett. 1991;288:123-128.
22. Brass LF. Homologous desensitization of HEL cell thrombin receptors: distinguishable roles for proteolysis and phosphorylation. J Biol Chem. 1992;267:6044-6050.
23. Hoxie JA, Ahuja M, Belmonte E, Pizarro S, Parton R, Brass LF. Internalization and recycling of activated thrombin receptors. J Biol Chem. 1993;268:13756-13763.
24. Hein L, Ishii K, Coughlin SR, Kobilka BK. Intracellular targeting and trafficking of thrombin receptors: a novel mechanism for resensitization of a G protein-coupled receptor. J Biol Chem. 1994;269: 27719-27726.
25. Kranzhöfer R, Clinton SK, Ishii K, Coughlin SR, Fenton JW II, Libby P. Thrombin potently stimulates cytokine production In human vascular smooth muscle cells but not in mononuclear phagocytes. Circ Res. 1996;79:286-294.
26. Okazaki H, Majesky MW, Harker LA, Schwartz SM. Regulation of platelet-derived growth factor ligand and receptor gene expression by α-thrombin in vascular smooth muscle cells. Circ Res. 1992;71: 1285-1293.
27. Walters TK, Gorog DA, Wood RFM. Thrombin generation following arterial injury is a critical initiating event in the pathogenesis of the proliferative stages of the atherosclerotic process. J Vasc Res. 1994;31:173-177.
28. Sarembock IJ, Gertz SD, Gimple LW, Owen RM, Powers ER, Roberts WC. Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation. 1991;84:232-243.
29. Sarembock IJ, Gertz SD, Thome LM, McCoy KW, Ragosta M, Powers ER, Maraganore JM, Gimple LW. Effectiveness of hirulog in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. J Vasc Res. 1996;33:308-314.
30. Unterberg C, Sandrock D, Nebendahl K, Buchwald AB. Reduced acute thrombus formation results in decreased neointimal proliferation after coronary angioplasty. J Am Coll Cardiol. 1995;26: 1747-1754.
31. Barry WL, Gimple LW, Humphries JE, Powers ER, McCoy KW, Sanders JM, Owens GK, Sarembock IJ. Arterial thrombin activity after angioplasty in an atherosclerotic rabbit model: time course and effect of hirudin. Circulation. 1996;94:88-93.
32. Nelken NA, Soifer SJ, O'Keefe J, Vu T-KH, Charo IF, Coughlin SR. Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest. 1992;90:1614-1621.
33. Wilcox JN, Rodriguez J, Subramanian R, Ollerenshaw J, Zhong C, Hayzer DJ, Horaist C, Hanson SR, Lumsden A, Salam TA, Kelly AB, Harker LA, Runge M. Characterization of thrombin receptor expression during vascular lesion formation. Circ Res. 1994;75: 1029-1038.
34. Schini-Kerth VB, Fisslthaler B, Van Obberghen-Schilling E, Busse R. Serotonin stimulates the expression of thrombin receptors in cultured vascular smooth muscle cells: role of protein kinase C and protein tyrosine kinases. Circulation. 1996;93:2170-2177.
35. Pircher R, Jullien P, Lawrence DA. β-Transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem Biophys Res Commun. 1986;136:30-37.
36. Scott-Burden T, Resink TJ, Baur U, Burgin M, Buhler FR. Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. Hypertension. 1989;13:295-304.
37. 1 in human smooth muscle cells. J Physiol. 1992;454: 451-465.
38. Wakefield LM, Smith DM, Flanders KC, Sporn MB. Latent transforming growth factor-β from human platelets: a high molecular weight complex containing precursor sequences. J Biol Chem. 1988; 263:7646-7654.
39. BB in vascular smooth muscle cells. Eur J Pharmacol. 1992;216:379-383.
40. Schini VB, Catovsky S, Schray-Utz B, R, Vanhoutte PM. Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells. Circ Res. 1994;74:24-32.
41. Assoian RK, Sporn MB. Type β transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol. 1986;102:1217-1223.
42. Hammacher A, Hellman U, Johnsson A, Ostman A, Gunnarsson K, Westermark B, Wasteson A, Heldin CH. A major part of plateletderived growth factor purified from human platelets is a heterodimer of one A and one B chain. J Biol Chem. 1988;263: 16493-16498.
43. Yan W, Tiruppathi C, Qiao R, Lum H, Malik AB. Tumor necrosis factor decreases thrombin receptor expression in endothelial cells. J Cell Physiol. 1996;166:561-567.
44. Schini-Kerth VB, Fisslthaler B, Andersen TT, Fenton JW II, Vanhoutte PM, Busse R. Thrombin prevents the expression of inducible nitric oxide synthase in vascular smooth muscle cells by a proteolytically-aetivated thrombin receptor. Thromb Haemost. 1995;74:980-986.
45. Groves HM, Kinlough-Rathbone RL, Richardson M, Moore S, Mustard JF. Platelet interaction with damaged rabbit aorta. Lab Invest. 1979;40:194-200.
46. Friedman RJ, Stemerman MB, Wenz B, Moore S, Gauldie J, Gent M, Tiell ML, Spaet TH. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits: smooth muscle cell proliferation and re-endothelialization, J Clin Invest. 1977;60:1191-1201.
47. Fingerle J, Johnson R. Clowes AW, Majesky MW, Reidy MA. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci U S A. 1989;86:8412-8416.
48. Shimokawa H, Vanhoutte PM. Angiographic demonstration of hyperconstriction induced by scrotonin and aggregating platelets in porcine coronary arteries with regenerated endothelium. J Am Coll Cardiol, 1991;17:1197-1202.
49. Sachinidis A, Locher R, Vetter W. Tatje D, Hoppe J. Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J Biol Chem. 1990;265:10238-10243.
50. Stouffer GA, Owens GK. TGF-β promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. J Clin Invest. 1994;93:2048-2055.
51. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J Cell Biol. 1988;106:1659-1665.
52. 1 by plasmin. J Cell Biol. 1990;110:1361-1367.
53. Bachmann F. Plasminogen activators. In: Colman RW, Hirsch J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, Pa: JB Lippincott Co; 1993:318-339.
54. Clowes AW, Clowes MM, Au YPT, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenests and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 1990;67:61-67.
55. Nemecek GM, Coughlin SR, Handley DA, Mosfcowitz MA. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci U S A. 1986;83:674-678.
56. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
57. Lindner V, Reidy A. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A. 1991;88:3739-3743.
58. Zhong C, Hayzer DJ, Corson MA, Runge MS. Molecular cloning of the rat vascular smooth muscle thrombin receptor: evidence for in vitro regulation by basic fibroblast growth factor. J Biol Chem. 1992;267:16975-16979.
59. DiCorletto PE, Bowen-Pope DF. Cultured endothelial cells produce a platelet-derived growth factor-like protein. Proc Natl Acad Sci U S A. 1983;50:1919-1923.
60. Martinet Y, Bitterman PB, Mornex JF, Grotendorst GR, Martin GR, Crystal RG. Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Nature. 1986;319:158-160.
61. Bachhuber BG, Sarembock IJ, Gimple LW, McNamara CA, Owens GK. Thrombin-induced mitogenesis in cultured aortic smooth muscle cells requires prolonged thrombin exposure. Am J Physiol. 1995;268:C1141-C1147.